Additional Details
-
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteNew York NY. 10029View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteGainesville FL. 32608View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteSalt Lake City UT. 84108View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteHouston TX. 77030View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteLos Angeles CA. 92868View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SitePotsdam NY. 13676View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SitePhiladelphia PA. 19140View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteTemple TX. 76508View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteNaples FL. 34102View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteSan Francisco CA. 94143View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteDurham NC. 27710View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteNew York NY. 10032View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteLos Angeles CA. 90033View Details -
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
GSK Investigational SiteLos Angeles CA. 90095View Details -
Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
Cedars-SinaiLos Angeles CA. 90048View Details -
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
MGH Institute of Health ProfessionsCharlestown MA. 02129View Details -
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
The University of Texas Health Science Center at HoustonHouston TX. 77030View Details -
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
MD Anderson Cancer CenterHouston TX. 77030View Details -
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Research SiteMontreal QC. H2X 0A9View Details
